Table 1.
Phenotype and genotype of NESTEGG short SGA (n = 240) and controls (n = 193). Data are presented as mean ± SD or percentage
| SGA (n = 240) | Controls (n = 193) | |
|---|---|---|
| Phenotype | ||
| Sex ratio (M/F) | 138/102 | |
| Birth length (SDS) | –2·9 ± 1·4 | |
| Birthweight (SDS) | –2·3 ± 1·0 | |
| Maternal height (SDS) | –1·0 ± 1·3 | |
| Paternal height (SDS) | –0·8 ± 1·0 | |
| Age at onset of GH treatment (years) | 6·6 ± 2·3 | |
| Height at start of GH treatment (SDS) | –3·0 ± 0·7 | |
| Weight at start of GH treatment (SDS) | –2·4 ± 0·9 | |
| GH dose (mg/kg/week) | 0·40 ± 0·17 | |
| Genotype | ||
| fl/fl, % (n) | 60 (144) | 51 (98) |
| fl/d3, % (n) | 27 (65) | 41 (80) |
| d3/d3, % (n) | 13 (31) | 8 (15) |